New York 2025-2026 Regular Session

New York Assembly Bill A07746

Introduced
4/8/25  
Refer
4/8/25  

Caption

Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.

Summary

Bill A07746 amends the public health law in New York to require that prescription bottles containing opioids have a specific warning label affixed to them. The label must state, 'Warning. This drug is highly addictive. Please consult your pharmacist or physician before using.' This measure aims to enhance awareness about the addictive nature of opioids among patients receiving these medications, thereby promoting safer usage and encouraging consultations with healthcare professionals.

Impact

The introduction of this bill will modify existing labeling requirements for prescription medications, specifically targeting opioids. By mandating a clear warning about the addictive potential of these substances, the bill seeks to influence patient behavior and potentially reduce misuse and addiction rates. The impact will extend to pharmacies and healthcare providers who will need to comply with the new labeling standards, thereby altering their dispensing practices.

Sentiment

The sentiment surrounding Bill A07746 appears to be supportive, as it addresses a critical public health issue related to opioid addiction. However, there may be concerns regarding the effectiveness of labeling alone in combating addiction and whether it places an undue burden on pharmacists and healthcare providers. Overall, discussions indicate a recognition of the need for heightened awareness about opioid risks.

Contention

Notable points of contention may arise regarding the practicality of implementing the new labeling requirements and whether the warning will effectively deter misuse. Some stakeholders, such as pharmacists, may express concerns about the additional responsibilities placed on them, while advocates for addiction prevention may argue that the bill does not go far enough in addressing the opioid crisis.

Companion Bills

No companion bills found.

Previously Filed As

NY A01022

Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.

NY SB1986

Relating to warning labels for opioid prescription drugs.

NY A3131

Requires labeling of over-the-counter and prescription drugs containing major food allergen or gluten-containing grain.

NY S07562

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY S05900

Relates to the distribution of educational materials regarding the misuse of and addiction to prescription drugs in counties with the most prevalent abuse of prescription opioids.

NY SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

NY HB2291

Opioids; containers; labeling; requirements; repeal

NY A08948

Relates to the distribution of educational materials regarding the misuse of and addiction to prescription drugs in counties with the most prevalent prescription substance use disorder.

NY SB2470

Relating to the requirements for the labeling and dispensing of a prescription drug or biological product.

NY S08827

Requires warning labels on addictive feature platforms which provide features such as addictive feeds, autoplay, infinite scroll, like counts, and/or push notifications; relates to the effectiveness of certain provisions of law relating thereto.

Similar Bills

No similar bills found.